About this policy
The comment period for the MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis Local Coverage Determination (LCD) began on 08/29/2024 and ended on 10/12/2024. The notice period will begin on 07/03/2025 and will end on 08/16/2025 becoming effective on 08/17/2025. The comments below were received from the provider community.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.